TAXUS Liberté SR Stent

paclitaxel-eluting stent · Boston Scientific Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TAXUS Liberté SR Stent, covering 2012-02-02 to 2012-02-02. Get the full timeline:

Most recent: Clinical Trial Update: TAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary Artery Lesions [Phase 3]